rAAV2-CBSB-hRPE65: Phase I data

Researchers at the university and colleagues reported data from 3 patients with LCA in an open-label, U.S. Phase I trial showing that a subretinal injection of rAAV2-CBSB-hRPE65 led to improvements in...